Q/C Technologies, Inc. share price logo

Q/C Technologies, Inc. Share Price

NASDAQ: QCLS

Small Cap

$3.69

-0.01

(-0.27%)

as on

Q/C Technologies, Inc. Stock Performance

as on April 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.61
    $4.10
    downward going graph

    2.17%

    Downside

    11.11%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Q/C Technologies, Inc. share price movements today

Previous Close
$3.70
Open
$3.70
Volume
1.3M
Day's Low - High
$3.61 - $4.10

Q/C Technologies, Inc. Historical Returns

1 Month Return
-3.9 %
3 Month Return
-22.43 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Q/C Technologies, Inc. Stock Fundamentals & Key Indicators

Check Q/C Technologies, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$28.0M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-40.64%

Q/C Technologies, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Q/C Technologies, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
NA$28.0MNANA0.00%
BUY$117.4B409.77%32.4635.64%
BUY$112.7B539.36%56.7919.59%
BUY$117.8B303.78%20.485.23%
BUY$185.6B678.42%53.3938.99%

Q/C Technologies, Inc. Stock’s Investor Sentiment and Interest

Search interest for Q/C Technologies, Inc. Stock has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-31% versus previous 30 day period

Q/C Technologies, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
Operating Income
-3
-1
-2
-2
-1
-1
EBITDA
-1
-1
-2
-2
-1
-
Interest Expense
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
Income Before Tax
-9
-1
-2
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
Net Income
-9
-1
-2
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Q/C Technologies, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Income
-28
-15
-17
-10
EBITDA
-29
-15
-16
-8
Interest Expense
0
-
-
-
Depreciation
-
-
-
-
Income Before Tax
-29
-15
-3
-23
Income Tax Expense
-
-
-
-
Net Income
-29
-15
-3
-23
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Q/C Technologies, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-9
-9
-1
-2
-1
-1
-2
Operating Cash Flow
-1
-2
-3
0
-2
-2
-1
Investing Cash Flow
0
-11
3
1
2
2
-1
Financing Cash Flow
-1
13
1
-1
-
-
9
Change in Cash
-2
0
0
-1
0
0
6

Q/C Technologies, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-29
-15
-3
-23
Operating Cash Flow
-19
-12
-12
-8
Investing Cash Flow
19
6
1
-6
Financing Cash Flow
0
5
13
12
Change in Cash
0
0
1
-2

Insights on Q/C Technologies, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, QCLS has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Sandisk Corp has given 2739.0% return, outperforming this stock by 2635.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, QCLS stock has moved down by -92.0%

About Q/C Technologies, Inc.

Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company also develops a silicon photonic computing architecture for AI inference. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
OrganisationQ/C Technologies, Inc.
Headquarters1185 Avenue of the Americas, New York, NY, United States, 10036
IndustryComputer Hardware
CEOMr. Joshua N. Silverman
E-voting on sharesClick here to vote

Key Management of Q/C Technologies, Inc.

Name

Title

Mr. Joshua N. Silverman

Executive Chairman of the Board

Mr. Ian Thomas Rhodes CPA

Chief Financial Officer

Dr. Mitchell Glass M.D.

Chief Medical Officer & Director

Robert Schatz

Investor Relations Officer

FAQs

What is Q/C Technologies, Inc. share price today?

Q/C Technologies, Inc. share price today is $3.69 as on at the close of the market. Q/C Technologies, Inc. share today touched a day high of $4.1 and a low of $3.61.

What is the 52 week high and 52 week low for Q/C Technologies, Inc. share?

Q/C Technologies, Inc. share touched a 52 week high of $ on and a 52 week low of $ on . Q/C Technologies, Inc. stock price today i.e. is closed at $3.69,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Q/C Technologies, Inc.'s market capitalisation today?

Q/C Technologies, Inc. market capitalisation is $0.00T as on .

How to invest in Q/C Technologies, Inc. Stock (QCLS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Q/C Technologies, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Q/C Technologies, Inc. Shares that will get you 0.4065 shares as per Q/C Technologies, Inc. share price of $3.69 per share as on April 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Q/C Technologies, Inc. Stock (QCLS) from India?

Indian investors can start investing in Q/C Technologies, Inc. (QCLS) shares with as little as ₹93.082 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹930.82 in Q/C Technologies, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Q/C Technologies, Inc. share’s latest price of $3.69 as on April 15, 2026 at 1:29 am IST, you will get 2.7100 shares of Q/C Technologies, Inc.. Learn more about fractional shares .